Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC10H10Cl2Ti |
InChIKeyYMNCCEXICREQQV-UHFFFAOYSA-L |
CAS Registry1271-19-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Titanocene dichloride | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 2 | Germany | - | |
Neoplasms | Phase 2 | United Kingdom | - | |
Neoplasms | Phase 2 | - | - |